Photo credit: Russian Direct Investment Fund Press service
In face of pandemic COVID-19, one of the most important government duties is its prevention and treatment, and above all, vaccine. Sputnik-V is the first vaccine in the world, and it was by Russian scientists from Gamaleya Research Institute of Epidemiology and Microbiology. It's worth mentioning that the vaccine is named after the first Soviet space satellite in 1957. Nonetheless the vaccine was criticized by some Western countries, many are interested in its acquisition. Especially Latin American countries, where the situation is still difficult. Russian center at University of Buenos Aires (UBA) organized online seminar for local medical scientists and specialists in order give full information on the Sputnik V vaccine.
According to the Russian Direct Investment Fund and Gamaleya Research Institute of Epidemiology and Microbiology, the priority task is upscaling vaccine production and meeting the vaccine needs in Russian Federation, as well as making it available for other countries by technology transfer and organization of its production abroad.
Scientific communities and health authorities from around the world have shown their interest in vaccine even at the time of its development. Right after its registration, 1,2 billion Sputnik-V vaccines were requested for purchase. Of this number, some 200 million doses were requested by Latin American countries.
Russian center at UBA together with Buenos Aires University itself and the Russkiy Mir Foundation launched series of informational sessions dedicated to achievements in medical science in Russia for Iberoamerican public and scientific community. Thus, local medical workers were engaged in three events promoting Sputnik V from August to October of 2020.
Last webinar, conducted on October, 30, has gathered more than 130 specialists from Latin America, India, and Russia. Russian center at UBA, All-India Foreign Medical Graduates Association, Russian Direct Investment Fund Press and Gamaleya Research Institute.
Gamaleya senior researcher, specialist of Genetic engineering of pathogens Dariya Egorova made a scientific presentation dedicated to the Sputnik V creation and its latest developments.
Head of ICU Service, Faculty of Fundamental Medicine at Lomonosov Moscow State University professor Sergey Tsarenko and the director of the Institute for Translational Medicine and Biotechnology of Sechenov University Vadim Tarasov made important reports on the issue supporting with up-to date practical information.
Q&A followed the major presentations. Director of Russian center at UBA Silvana Yarmolyuk-Stroganova from Buenos Aires (Argentina) and All-India Foreign Medical Graduates Association secretary, doctor Sanjay Mukundan.
In conclusion, the words of gratitude to the vaccine creators were expressed by the head of Kerala association of medical graduates from abroad, doctor Benzilal (on behalf of Indian doctors) and by Peruvian doctor Pedro Grillo Rojas, on behalf of Latin-American graduates from USSR institutes.
Being one of the first events organised by Russian center at UBA, this webinar has demonstrated very serious interest of foreign specialists in Russian vaccine. The event was organised in the frames of extensive international awareness-raising online program PAX RUSSIKA.
“PAX RUSSIKA aims to build a positive image of Russia abroad, it is an active promotion of our moral and cultural values, our achievements in science, education, arts,” said Yarmolyuk Stroganova. The first official presentation of the program is going to take place in the frames of the Russkiy Mir Assembly on November, 10, 17:00 Moscow time on Russkiy Mir Foundation youtube channel.
The link to the
Pax Russika forum will be available on the same day, 30 min before the beginning.
Note
On August, 11 2020 the Sputnik-V vaccine has received the Russian Health Ministry registration certificate. It was developed and is being produced by Gamaleya Research Institute of Epidemiology and Microbiology with support of the Russian Direct Investment Fund.